Literature DB >> 8084592

Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment.

J Pastorek1, S Pastoreková, I Callebaut, J P Mornon, V Zelník, R Opavský, M Zat'ovicová, S Liao, D Portetelle, E J Stanbridge.   

Abstract

MN is a transmembrane glycoprotein that has been detected in HeLa cells and in some human carcinomas. The expression of MN protein in HeLa cells is regulated by cell density. In HeLa x fibroblast cell hybrids its expression correlates with tumorigenicity. Using a specific monoclonal antibody we have identified a cDNA clone coding for MN. Analysis of the deduced amino acid sequence revealed strong structural homology between the central region of the MN protein and carbonic anhydrases (CA). MN sequence retains the conserved zinc-binding site as well as the enzyme's active center. In accord with these findings, MN protein from HeLa cells was found to bind zinc and to have carbonic anhydrase activity. The N-terminal region of MN shares some similarity with DNA binding proteins of the helix-loop-helix (HLH) family, and the protein was found to have affinity for DNA by DNA-cellulose chromatography. The region between the CA-like domain and the putative HLH domain is rich in imperfect repeats of serine, proline, glycine and acidic residues with few hydrophobic amino acids, resembling thus an activation region of transcription factors. The fact that MN protein is detectable in several types of human carcinomas, but not in corresponding non-cancerous tissues, suggests its possible role in neoplasia. In addition, the analysis of biological consequences of MN expression of NIH3T3 cells provides the evidence in favour of MN protein involvement in control of cell proliferation and transformation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084592

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  135 in total

1.  Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells.

Authors:  Ying Li; Hai Wang; Chingkuang Tu; Kathleen T Shiverick; David N Silverman; Susan C Frost
Journal:  Biochim Biophys Acta       Date:  2010-10-12

Review 2.  Kidney cancer management in 2004: an update for the practicing general urologist.

Authors:  John S Lam; Oleg Shvarts; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2004-02       Impact factor: 3.092

3.  Expression of ROR1 in patients with renal cancer--a potential diagnostic marker.

Authors:  Hodjattallah Rabbani; Mahyar Ostadkarampour; Amir Hossein Danesh Manesh; Abbas Basiri; Mahmood Jeddi-Tehrani; Flora Forouzesh
Journal:  Iran Biomed J       Date:  2010-07

4.  Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.

Authors:  Harun M Said; Adrian Staab; Carsten Hagemann; Giles H Vince; Astrid Katzer; Michael Flentje; Dirk Vordermark
Journal:  J Neurooncol       Date:  2006-08-31       Impact factor: 4.130

5.  Expression of hypoxic marker CA IX is regulated by site-specific DNA methylation and is associated with the histology of gastric cancer.

Authors:  Jun Nakamura; Yoshihiko Kitajima; Keita Kai; Kazuyoshi Hashiguchi; Masatsugu Hiraki; Hirokazu Noshiro; Kohji Miyazaki
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 6.  Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

Authors:  Stefan Kaluz; Milota Kaluzová; Shu-Yuan Liao; Michael Lerman; Eric J Stanbridge
Journal:  Biochim Biophys Acta       Date:  2009-01-22

Review 7.  G250: a carbonic anhydrase IX monoclonal antibody.

Authors:  John S Lam; Allan J Pantuck; Arie S Belldegrun; Robert A Figlin
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

8.  The role of carbonic anhydrases in tumors.

Authors:  A Nógrádi
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

9.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015

10.  Regulation of hypoxia-inducible genes by ETS1 transcription factor.

Authors:  Konstantin Salnikow; Olga Aprelikova; Sergey Ivanov; Sean Tackett; Monika Kaczmarek; Aldona Karaczyn; Herman Yee; Kazimierz S Kasprzak; John Niederhuber
Journal:  Carcinogenesis       Date:  2008-04-01       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.